NxStage Medical Inc.
NXTM
NXTM was delisted on the 21st of February, 2019.
140 hedge funds and large institutions have $924M invested in NxStage Medical Inc. in 2016 Q1 according to their latest regulatory filings, with 26 funds opening new positions, 57 increasing their positions, 40 reducing their positions, and 25 closing their positions.
320% more call options, than puts
Call options by funds: $2.22M | Put options by funds: $528K
43% more repeat investments, than reductions
Existing positions increased: 57 | Existing positions reduced: 40
4% more first-time investments, than exits
New positions opened: 26 | Existing positions closed: 25
0% more funds holding
Funds holding: 140 → 140 (0)
29% less funds holding in top 10
Funds holding in top 10: 7 → 5 (-2)
29% less capital invested
Capital invested by funds: $1.31B → $924M (-$382M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$19.7M |
| 2 |
SAM
Sectoral Asset Management
Montreal,
Quebec, Canada
|
+$15.9M |
| 3 |
DM
Deerfield Management
New York
|
+$15.4M |
| 4 |
CCM
Cadian Capital Management
New York
|
+$8.1M |
| 5 |
Allianz Asset Management
Munich,
Germany
|
+$7.63M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RIM
RS Investment Management
San Francisco,
California
|
-$10M |
| 2 |
OIM
Oracle Investment Management
Greenwich,
Connecticut
|
-$9.99M |
| 3 |
CM
Castleark Management
Chicago,
Illinois
|
-$8.84M |
| 4 |
Massachusetts Financial Services
Boston,
Massachusetts
|
-$7.4M |
| 5 |
BIM
Bogle Investment Management
Newton Lower Falls,
Massachusetts
|
-$6.69M |
NXTM Hedge Fund Activity: Q1 2016 in Review
140 of the 3,767 institutional investors tracked by Wall St. Rank reported a position in NxStage Medical Inc. (NXTM) for Q1 2016, worth a combined $924M — down 29% from $1.31B a quarter earlier.
Buyers outnumbered sellers: 26 funds opened new NXTM positions and 25 closed out — a net gain of 1 holder — while 57 added to existing stakes and 40 trimmed.
The largest buyer was Fidelity Investments, adding an estimated $19.7M. The largest seller was RS Investment Management, cutting an estimated $10M.
- 140 institutional investors held NxStage Medical Inc. (NXTM) as of Q1 2016, unchanged from Q4 2015.
- Funds reported $924M of NxStage Medical Inc. stock for Q1 2016, down 29% quarter-over-quarter.
- 26 funds opened new NxStage Medical Inc. positions in Q1 2016 and 25 closed out, a net change of +1 holder.
- The largest NxStage Medical Inc. buyer in Q1 2016 was Fidelity Investments, an estimated $19.7M added.
- The largest NxStage Medical Inc. seller in Q1 2016 was RS Investment Management, an estimated $10M sold.
Based on aggregated 13F filings for Q1 2016.